Can a targeted antibody stop severe hepatitis from destroying Children's livers?
Disease control
Not yet recruiting
This trial tests whether a medicine called emapalumab, which calms a specific part of the immune system, can prevent liver failure in children aged 1 year and older with severe hepatitis that hasn't improved with steroids. The study includes a screening group to observe all sever…
Phase 2 • Sponsor: Children's Healthcare of Atlanta • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC